TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive Clinical Research: Enough Studies Done, Time For Solutions, CSR Report Says February 20, 1998
TCL Archive New Biologic Modalities Show Promise In Treatment Of Lymphomas, Research Finds June 28, 2002